Therion Biologics Constructs Production Facility

Published March 2003

CAMBRIDGE, MASS. -

Therion Biologics of Cambridge, Mass. is constructing a $5-million, 10,000-sf production facility for two cancer vaccines which are in Phase II clinical trials.

Copyright 2008 Tradeline Inc.
All Rights Reserved
ISSN: 1096-4894